Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma
文献类型：期刊论文
| 作者 | Ambrogio, Chiara ; Gomez-Lopez, Gonzalo ; Falcone, Mattia ; Vidal, August ; Nadal, Ernest ; Crosetto, Nicola ; Blasco, Rafael B. ; Fernandez-Marcos, Pablo J. ; Sanchez-Cespedes, Montserrat ; Ren, Xiaomei ; Wang, Zhen ; Ding, Ke ; Hidalgo, Manuel ; Serrano, Manuel ; Villanueva, Alberto ; Santamaria, David ; Barbacid, Mariano |
| 刊名 | NATURE MEDICINE
 |
| 出版日期 | 2016 |
| 卷号 | 22期号:3页码:270-277 |
| ISSN号 | 1078-8956 |
| 学科主题 | Biochemistry & Molecular Biology ; Cell Biology ; Research & Experimental Medicine |
| 语种 | 英语 |
| 公开日期 | 2016-12-16 |
| 源URL | [http://ir.gibh.ac.cn/handle/344009/884]  |
| 专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
| 推荐引用方式 GB/T 7714 | Ambrogio, Chiara,Gomez-Lopez, Gonzalo,Falcone, Mattia,et al. Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma[J]. NATURE MEDICINE,2016,22(3):270-277. |
| APA | Ambrogio, Chiara.,Gomez-Lopez, Gonzalo.,Falcone, Mattia.,Vidal, August.,Nadal, Ernest.,...&Barbacid, Mariano.(2016).Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma.NATURE MEDICINE,22(3),270-277. |
| MLA | Ambrogio, Chiara,et al."Combined inhibition of DDR1 and Notch signaling is a therapeutic strategy for KRAS-driven lung adenocarcinoma".NATURE MEDICINE 22.3(2016):270-277. |
入库方式： OAI收割
来源：广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。